🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform

RecruitingNAAges 18 Years - anyAllUniversitätsklinikum Hamburg-Eppendorf
NCT07884994 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Severe obesity is a chronic condition that can lead to a range of serious health problems. One common treatment option is sleeve gastrectomy, a weight-loss operation in which the size of the stomach is reduced. These procedures are increasingly being performed with the support of robotic surgical systems. However, there is still limited clinical experience with the Hugo™ Robotic-Assisted Surgery System for this type of operation. The aim of this study is to evaluate whether sleeve gastrectomy can be performed safely and reliably using the Hugo™ system. In particular, the study will assess whether the operation can be completed as planned with the robotic system and will examine outcomes during and after surgery. The study will include 50 adults with severe obesity who are scheduled to undergo sleeve gastrectomy. Information will be collected during the operation, including the duration

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Body mass index (BMI) ≥ 40 kg/m², or BMI ≥ 35 kg/m² in the presence of at least one obesity-related comorbidity * Scheduled for elective primary sleeve gastrectomy * Ability to provide written informed consent * Sufficient language proficiency to participate in the study. Exclusion Criteria: * Previous upper abdominal surgery * Revisional bariatric surgery * American Society of Anesthesiologists (ASA) physical status classification ≥ IV * Oral anticoagulation therapy * Presence of a ventriculoperitoneal shunt * Severe hepatomegaly or other contraindications to a robotic surgical approach
💊

What it tests

  • Sleeve Gastrectomy using Hugo RAS platform
📍

Where

1 site
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy